Radiotherapy Dose Escalation in Unresectable Ewing’s Sarcoma/ PNET: Final Results of a Phase III Randomized Controlled Trial
Volume: 105, Issue: 1, Pages: S62 - S62
Published: Sep 1, 2019
Abstract
Assess the impact of radiotherapy (RT) dose escalation on disease related outcomes in surgically unresectable Ewing’s sarcoma/ PNET. Patients with non-metastatic unresectable Ewing’s sarcoma/ PNET (excluding intracranial/chest wall) treated with definitive RT were accrued in this single institute open label phase III randomized controlled trial. Randomization was between standard dose RT (SDRT: 55.8Gy/31 fractions/5 days a week) vs. escalated...
Paper Details
Title
Radiotherapy Dose Escalation in Unresectable Ewing’s Sarcoma/ PNET: Final Results of a Phase III Randomized Controlled Trial
Published Date
Sep 1, 2019
Volume
105
Issue
1
Pages
S62 - S62
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History